VPI-2690B

· Vascular Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VPI-2690B, covering 2017-03-28 to 2017-03-28. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Study to Evaluate Safety & Efficacy of VPI-2690B in Diabetic Nephropathy Patients [Phase 2]